This systematic review and economic evaluation, published in 2012, assessed the clinical and cost-effectiveness of pharmacological interventions for obesity management in primary care settings. The study analyzed data from randomized controlled trials focusing on orlistat, sibutramine, and rimonabant. All three medications demonstrated modest weight loss benefits compared to placebo, with
